REFERENCES
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibilty testing: 4th informational supplement. M100-S4. NCCLS, Villanova, PA, 1992.
- York MK. Reporting susceptibility test results - are we really communicating with physicians? Clin Microbiol Newslett 1996; 18: 177-182.
- Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994; 32: 1757-1762.
- Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience -with selective reporting of susceptibility to antimicrobial agents. Am J Hosp Pharm 1989; 46: 1816-1818.
- Biedenbach DJ, Jones RN. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam. Diagn Microbiol Infect Dis 1995; 21: 57-60.
- Marshall SA, and the Aztreonam Study Group. Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Diagn Microbiol Infect Dis 1995; 22: 249-251.
- Cunha BA, Ortega AM. Antibiotic failure. Med Clin North Am 1995; 79: 663-672.
- Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspective on measures needed for control. Ann Intern Med 1996; 124: 329-334.
- Cunha BA, Comer JB. Pharmacokinetic considerations in the treatment of urinary tract infections. Connecticut Med 1979; 43:347-353.
- Nicolle LE. Measurement and signficance of antibiotic activity in the urine. In: Lorian V (ed). Antibiotics in Laboratory Medicine, ed. 4. Baltimore, Williams & Wilkins, 1996: 793-812.
- Johnson CC. In vitro testing: correlations of bacterial susceptibility, body fluid levels, and effectiveness of antibacterial therapy. In: Lorian V (ed). Antibiotics in Laboratory Medicine, ed. 4. Baltimore, Williams & Wilkins, 1996: 813-834.
- Stamey TA, Fair WR, Timothy MM. Serum versus urinary antimicrobial concentration in cure of urinary tract infections. N Engl J Med 1974; 291: 1159-1163.
- Shea KW, Cunha BA. Doxycycline activity against Streptococcus pneumoniae. Chest 1995; 108: 1175-1176.
- Lorian V, Sabath LD. Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli. Applied Microbiol 1970; 20: 754-756.
- Absalon J, Domenico P, Ortega AM, Cunha BA, Qadri SMH. The antibacterial activity of ofloxacin versus ciprofloxacin against Pseudomonas aeruginosa in human urine. Adv Ther 1996; 13: 29-37.